First Horizon Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $350K | Buy |
900
+59
| +7% | +$23.7K | 0.01% | 412 |
|
|
2025
Q1 | $366K | Buy |
841
+127
| +18% | +$51K | 0.01% | 388 |
|
|
2024
Q4 | $263K | Sell |
714
-140
| -16% | -$58.6K | 0.01% | 460 |
|
|
2024
Q3 | $444K | Buy |
854
+52
| +6% | +$27.8K | 0.01% | 369 |
|
|
2024
Q2 | $435K | Sell |
802
-71
| -8% | -$37.5K | 0.01% | 356 |
|
|
2024
Q1 | $453K | Buy |
873
+38
| +5% | +$18.9K | 0.01% | 342 |
|
|
2023
Q4 | $394K | Buy |
835
+70
| +9% | +$32.4K | 0.01% | 357 |
|
|
2023
Q3 | $333K | Buy |
765
+88
| +13% | +$39.9K | 0.01% | 372 |
|
|
2023
Q2 | $301K | Sell |
677
-11
| -2% | -$5.07K | 0.01% | 408 |
|
|
2023
Q1 | $316K | Sell |
688
-6
| -0.9% | -$2.85K | 0.01% | 389 |
|
|
2022
Q4 | $356K | Sell |
694
-8
| -1% | -$4.06K | 0.01% | 365 |
|
|
2022
Q3 | $318K | Sell |
702
-34
| -5% | -$16.3K | 0.01% | 367 |
|
|
2022
Q2 | $353K | Buy |
736
+534
| +264% | +$264K | 0.01% | 373 |
|
|
2022
Q1 | $99K | Sell |
202
-432
| -68% | -$197K | 0.01% | 494 |
|
|
2021
Q4 | $293K | Sell |
634
-46
| -7% | -$19.4K | 0.01% | 437 |
|
|
2021
Q3 | $252K | Buy |
680
+71
| +12% | +$27K | 0.01% | 459 |
|
|
2021
Q2 | $232K | Sell |
609
-31
| -5% | -$11.8K | 0.01% | 379 |
|
|
2021
Q1 | $229K | Buy |
640
+13
| +2% | +$4.18K | 0.01% | 361 |
|
|
2020
Q4 | $201K | Sell |
627
-91
| -13% | -$27.9K | 0.01% | 322 |
|
|
2020
Q3 | $192K | Sell |
718
-41
| -5% | -$11K | 0.01% | 309 |
|
|
2020
Q2 | $198K | Sell |
759
-78
| -9% | -$20.8K | 0.02% | 305 |
|
|
2020
Q1 | $189K | Buy |
837
+24
| +3% | +$6.54K | 0.02% | 296 |
|
|
2019
Q4 | $245K | Hold |
813
| – | – | 0.02% | 309 |
|
|
2019
Q3 | $194K | Hold |
813
| – | – | 0.02% | 329 |
|
|
2019
Q2 | $228K | Sell |
813
-70
| -8% | -$19.1K | 0.02% | 327 |
|
|
2019
Q1 | $253K | Sell |
883
-58
| -6% | -$16.8K | 0.02% | 302 |
|
|
2018
Q4 | $246K | Buy |
941
+3
| +0.3% | +$825 | 0.02% | 298 |
|
|
2018
Q3 | $256K | Buy |
938
+129
| +16% | +$33.5K | 0.02% | 333 |
|
|
2018
Q2 | $192K | Buy |
809
+92
| +13% | +$21.3K | 0.02% | 364 |
|
|
2018
Q1 | $158K | Sell |
717
-19
| -3% | -$4.46K | 0.02% | 333 |
|
|
2017
Q4 | $171K | Buy |
736
+78
| +12% | +$16.6K | 0.02% | 335 |
|
|
2017
Q3 | $125K | Sell |
658
-6
| -0.9% | -$1.14K | 0.01% | 361 |
|
|
2017
Q2 | $127K | Sell |
664
-4
| -0.6% | -$719 | 0.01% | 357 |
|
|
2017
Q1 | $117K | Buy |
668
+67
| +11% | +$10.7K | 0.01% | 385 |
|
|
2016
Q4 | $73K | Hold |
601
| – | – | 0.01% | 450 |
|
|
2016
Q3 | $73K | Buy |
601
+48
| +9% | +$6.2K | 0.01% | 445 |
|
|
2016
Q2 | $72K | Buy |
553
+116
| +27% | +$15.9K | 0.01% | 445 |
|
|
2016
Q1 | $59K | Buy |
437
+386
| +757% | +$51.6K | 0.01% | 501 |
|
|
2015
Q4 | $7K | Sell |
51
-272
| -84% | -$37.5K | ﹤0.01% | 983 |
|
|
2015
Q3 | $45K | Sell |
323
-2
| -0.6% | -$301 | 0.01% | 551 |
|
|
2015
Q2 | $53K | Buy |
325
+39
| +14% | +$6.23K | 0.01% | 533 |
|
|
2015
Q1 | $44K | Sell |
286
-56
| -16% | -$7.97K | 0.01% | 584 |
|
|
2014
Q4 | $43K | Buy |
342
+51
| +18% | +$6.3K | 0.01% | 583 |
|
|
2014
Q3 | $34K | Sell |
291
-15
| -5% | -$1.72K | 0.01% | 640 |
|
|
2014
Q2 | $33K | Buy |
306
+228
| +292% | +$23.5K | ﹤0.01% | 668 |
|
|
2014
Q1 | $8K | Hold |
78
| – | – | ﹤0.01% | 1011 |
|
|
2013
Q4 | $7K | Hold |
78
| – | – | ﹤0.01% | 1020 |
|
|
2013
Q3 | $7K | Buy |
+78
| New | +$6.68K | ﹤0.01% | 895 |
|
Other funds holding ELV
First Horizon Advisors's ELV Position: Q2 2025 in Review
First Horizon Advisors increased its Elevance Health (ELV) stake by 7% in Q2 2025, buying an estimated $23.7K and bringing the position to 900 shares worth $350K. The position accounts for 0.01% of the portfolio, ranked #412.
First Horizon Advisors first reported a position in ELV in Q3 2013 and has held it in 48 quarters since. The position peaked at $453K in Q1 2024. 1,590 funds tracked by Wall St. Rank hold ELV as of Q2 2025.
- First Horizon Advisors held 900 shares of Elevance Health worth $350K as of Q2 2025.
- First Horizon Advisors bought 59 Elevance Health shares in Q2 2025, an estimated $23.7K.
- Elevance Health made up 0.01% of First Horizon Advisors's portfolio in Q2 2025, its #412 holding.
- First Horizon Advisors first reported a position in Elevance Health in Q3 2013 and has held it in 48 quarters since.
- First Horizon Advisors's Elevance Health position peaked at $453K in Q1 2024.
- 1,590 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.